TARDBP and amyotrophic lateral sclerosis: These observations highlight the potential role of APG in mitigating ALS-related neurodegenerative changes by preventing abnormal TDP-43 aggregation and restoring normal neuronal protein distribution, providing a potential therapeutic strategy to improve clinical symptoms and prolong survival in ALS patients.